The aspirin targets COX-1 and 2 are associated with the upstream PI3K signaling axis, but because these enzymes are also inhibited by other NSAIDs, it is difficult to explain why the clinical effect of aspirin is specific to the drug, particularly in the context of prevention/treatment of PIK3CA-mutated CRC. The gene discussed is PIK3CG; the disease is colorectal carcinoma.